Amundi Reduces Stake in Option Care Health, Inc. (NASDAQ:OPCH)

Amundi lessened its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 11.1% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 641,061 shares of the company’s stock after selling 80,100 shares during the quarter. Amundi owned about 0.38% of Option Care Health worth $15,475,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of OPCH. Cornerstone Investment Partners LLC boosted its position in shares of Option Care Health by 3.6% in the fourth quarter. Cornerstone Investment Partners LLC now owns 9,544 shares of the company’s stock valued at $221,000 after acquiring an additional 333 shares during the period. UMB Bank n.a. lifted its stake in Option Care Health by 41.7% in the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock worth $27,000 after purchasing an additional 346 shares in the last quarter. Assetmark Inc. boosted its holdings in Option Care Health by 2.0% in the 4th quarter. Assetmark Inc. now owns 24,976 shares of the company’s stock valued at $579,000 after purchasing an additional 487 shares during the period. Lindenwold Advisors INC grew its position in shares of Option Care Health by 5.4% during the 3rd quarter. Lindenwold Advisors INC now owns 9,548 shares of the company’s stock valued at $299,000 after purchasing an additional 489 shares in the last quarter. Finally, Pacer Advisors Inc. increased its holdings in shares of Option Care Health by 2.2% in the fourth quarter. Pacer Advisors Inc. now owns 25,483 shares of the company’s stock worth $591,000 after purchasing an additional 537 shares during the period. 98.05% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on OPCH shares. JPMorgan Chase & Co. lifted their price objective on Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a research note on Thursday, March 6th. Jefferies Financial Group upgraded Option Care Health from a “hold” rating to a “buy” rating and lifted their price target for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. JMP Securities restated a “market outperform” rating and issued a $30.00 price objective (down from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. UBS Group assumed coverage on shares of Option Care Health in a research note on Thursday, December 5th. They issued a “neutral” rating and a $26.00 target price on the stock. Finally, Barrington Research boosted their price target on shares of Option Care Health from $33.00 to $38.00 and gave the stock an “outperform” rating in a research note on Thursday, February 27th. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $33.00.

Option Care Health Stock Down 2.0 %

Shares of NASDAQ OPCH opened at $32.24 on Friday. The stock has a market capitalization of $5.33 billion, a P/E ratio of 27.09, a PEG ratio of 2.30 and a beta of 1.33. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $34.85. The firm’s 50 day simple moving average is $30.63 and its two-hundred day simple moving average is $28.25. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32.

Insider Activity at Option Care Health

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the business’s stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the sale, the insider now directly owns 44,974 shares of the company’s stock, valued at $1,495,835.24. The trade was a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 0.64% of the stock is owned by insiders.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.